Chapter 20: Fungi: Medical Mycology

0:00 / 0:00
Report an issue

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

You know, usually when we talk about microbiology, it feels like it's all about humans versus bacteria or humans versus viruses.

Right, a very us versus them kind of thing.

Exactly.

But today, we are stepping into a whole other kingdom, one that's a little more alien.

I mean, it recycles the world's waste, it puts mushrooms on our pizza, but it also has members that can literally eat through bone.

It really is a different beast entirely.

We're talking about the kingdom Mycota, fun guy.

And to navigate this, this fungal jungle, we're diving deep into chapter 20 of Lippincott Illustrated Reviews, Microbiology, the fourth edition.

A fantastic resource.

Our mission today is pretty straightforward.

Take this dense chapter and decode it step by step for medical students, college students, anyone who really wants to understand what they're up against.

And it is a massive topic.

I mean, most people hear fungus and they just think of, what, athlete's foot.

Yeah, something annoying.

But for a clinician, fungi can represent some of the absolute toughest infections to treat, especially in patients with weakened immune systems.

So let's start with that identity crisis.

The text makes a big deal about classification right away.

Where do fungi even fit?

This is maybe the most important concept to get because it changes everything about treatment.

Fungi are eukaryotes.

Okay, so they're like us.

Deceptively like us.

Bacteria, prokaryotes, they're simple, no nucleus, a very different machinery, but a fungal cell.

It has a nucleus, it has mitochondria.

All the same organelles.

In many ways, yeah, it looks a lot like one of our cells.

Which I'm guessing makes killing them without killing the patient a challenge.

A huge challenge.

I mean, if you design a drug that kills eukaryotic cells, you might just poison the person you're trying to fave.

That's why we have hundreds of antibiotics, but really just a handful of good anti -fungal drugs.

But the source material does point out a few key differences.

They aren't exactly like us.

Right, and they're not plants either.

No chlorophyll, so they can't use sunlight for food.

They're what we call chemoheterotrophs.

Which is just a fancy way of saying they have to eat other things.

It is, but they do it by secreting enzymes to digest their food outside their bodies, and then they just absorb the nutrients.

A stomach on the outside.

Great image.

It's effective, but for a medical student, the real money is in the structural differences.

You have to find what they have that we don't, and the text highlights two big ones.

The cell wall and the cell membrane.

Okay, let's break those down.

We don't have cell walls.

Bacteria have peptidoglycan.

What are fungi wearing?

They're wearing armor made of chitin.

Chitin, like in an insect's exoskeleton?

The very same.

It's an incredibly tough polymer, and this is why penicillin does absolutely nothing to a fungal infection.

Because it's targeting the wrong material.

Exactly.

It attacks peptidoglycan.

Fungi don't have it.

It just bounces off the chitin.

Okay, that's target one.

What about the membrane?

This is where most of our drugs work.

So our cell membranes use cholesterol for stability.

Fungal membranes use a similar but distinct molecule called ergosterol.

Ergosterol.

Got it.

And that distinct part is what we exploit.

Most of our antifungal drugs are designed to go after ergosterol.

The chapter lists a few classes, and this feels really high yield.

Let's group them by how they attack.

I like to think of them as the hole punchers and the synthesis blockers.

Ha!

Okay, I like that.

Who are the hole punchers?

That would be the polyenes.

The big names are amphotericin B and nastatin.

They find ergosterol in the membrane, bind to it, and just rip a hole right through it.

So the cell's contents just leak out.

And it dies.

Simple and brutal.

Now amphotericin B, that's the one they call amphoterrable, isn't it?

It is.

Because ergosterol is just similar enough to our cholesterol, the amphotericin B can sometimes punch holes in our souls, too.

Especially the kidneys.

It is a very, very big gun.

Okay, so if we want to be a bit more subtle.

Then you use the azoleses.

Fuconazole, aconazole,

they don't punch holes, they just stop the fungus from making ergosterol in the first place.

They block a specific enzyme,

a P450 enzyme, 14 -alpha -sterol -temethylase.

No enzyme, no ergosterol, no stable membrane.

Much cleaner.

Generally, yes.

And then you have a newer class, the achinocandins.

They go after the cell wall instead.

They block the synthesis of something called beta -1 -UK3 -glucan.

It's like taking the mortar out from between the bricks.

And there was one more, flucitacin.

Right, 5 -FC.

That one's clever.

It gets inside the cell using a transport protein that we don't have, and then it messes up their DNA and protein synthesis from the inside.

Okay, so before we get to the diseases, we have to talk about what these things actually look like, because the tech says they're basically shapeshifters.

They are.

They usually take one of two main forms.

First, you have yeasts.

Those are single -celled, round, and they reproduce by budding.

Just picture a little balloon growing off the side of a bigger one.

And the other form.

That would be the filamentous moles, the fuzzy stuff on old bread.

They grow as these long threads called hyphae, and a whole mat of hyphae is called a mycelium.

But here's the key concept from the chapter.

Some of them can be both.

Yes.

This is dimorphism.

Two forms.

And it is absolutely crucial, because almost all of the really bad systemic pathogens are dimorphic.

And they switch based on what?

Temperature.

The classic mnemonic is mold in the cold, yeast in the beast.

Huh.

I love that.

In the soil, where it's cool, they grow as a mold.

But when you inhale their spores and they land in your lungs,

the 37 degrees Celsius beast, they transform into a yeast.

It's a key part of their pathogenic strategy.

And these spores, that's how they spread.

Mostly, yeah.

Asexual spores are called knidia, that dusty powder on a moldy piece of fruit.

Millions of knidia.

They just float in the air and we breathe them in all the time.

So in the lab, how do you tell what you're dealing with?

The go -to is Sabirondextro's agar.

It's a special growth medium with a really low pH, around 5 .0.

And that's to?

Kill bacteria.

Most bacteria can't handle that acidity, but fungi thrive in it.

It clears the plate for them to grow.

Smart.

And for a quicker diagnosis?

You can do a direct stain, take a scraping, add some tassium hydroxide, or KOH.

It dissolves all the human cells, but the tough Keaton walls of the fungus remain.

So you can see the hyphae right away under the microscope.

Okay, biology is down.

Let's move into the clinical side.

The chapter organizes infections by how deep they go.

Right.

Surface level and then working our way in.

So we start with the cutaneous mycosis.

Skin, hair, and nails.

The dermatophytes.

The common annoyances.

Very common.

The three main genera are trichophyton,

epidermophyton, and microsporum.

And the key thing to remember is that they're not trying to invade your body.

They're just hunger for keratin.

The protein in our skin and nails.

Exactly.

They just live on the dead outer layers.

And we call these infections tinea.

Let's run through them.

Tinea pedis.

Athlete's foot.

Usually starts between the toes.

The real danger isn't the fungus itself, but the cracks it causes in the skin, which can lead in a nasty secondary bacterial infection.

Tinea corporis.

That's ringworm.

It's not a worm, of course.

It's the fungus growing outwards in a circle, creating that classic red scaly ring.

What about tinea capitis?

Scalp ringworm.

And the text has this really cool diagnostic pearl for this one.

If it's caused by microsporum, the infected hairs will fluoresce a bright green under a wood lamp.

A UV light.

Yep.

Hard to miss.

And the last one, the one everyone hates.

Tinea unglium.

Onychomycosis.

Nail fungus.

Makes the nails thick, yellow, and brittle.

And it's so hard to treat because topicals can't penetrate the nail.

You usually need months of oral medication.

Okay, let's go one layer deeper.

Subcutaneous mycosis.

Right.

So these aren't just landing on your skin, they're being forced in.

Traumatic implantation.

Like getting poked by a thorn.

Exactly.

The classic example is Rose Gardner's disease.

Sporatricosis.

Right.

Caused by sporothrax chinky.

A gardener gets pricked by a thorn.

A little ulcer forms at the site.

But then, and this is the key sign, you start seeing more nodules popping up in a line, going up the arm.

You're following the lymphatic channels.

Precisely.

It's an ascending lymphangitis, a line of bumps on a gardener's arm.

Yeah.

You have to think sporothrax.

The other one they mention is mysotoma, or Madura foot.

Yeah, that's a chronic nasty abscess, usually on the foot.

The diagnostic giveaway is that the pus contains these little colored grains.

Grains, like sand.

They look like it, but they're actually clumps of fungal hyphae.

They can be black, white, red,

and the color helps you identify the species.

All right, now we are leaving the annoying category and entering the truly dangerous one.

The systemic mycosis.

The true pathogens.

Why that name, true pathogen?

Because these can cause serious disease in perfectly healthy people.

You don't need to be immunocompromised, you just have to breathe in enough spores from the soil, and they're all dimorphic.

Mold in the cold, yeast in the beast.

You got it.

The book organizes these by geography, which is really helpful, so let's play detective.

A patient from the San Joaquin Valley in California has a lung infection.

That's Cuxidioidomycosis, valley fever.

The dust in the deserts of the southwest is full of it.

And what's the telltale sign under the microscope?

You're not looking for yeast, you're looking for spirals.

Big, round sacs, just packed with little endospores.

You see a spiral in the lung, you've got your diagnosis.

Okay, next case.

A patient when exploring caves in the Ohio River Valley.

Caves mean bat droppings.

Ohio River Valley means histoplasmosis.

Histoplasma loves soil enriched with bird or back guano.

And its microscopic trick.

It's an intracellular parasite.

It lives and multiplies inside our macrophages.

The slides show these immune cells just stuffed full of tiny yeast cells.

Wow.

Okay, how about a patient from the southeast U .S.?

You should think blastomycosis, blastomyces.

The visual cue here is the yeast itself.

It has a very characteristic broad -based bud.

A broad -based bud?

Like a snowman with a really thick neck.

That's a perfect way to picture it.

The connection between the parent and daughter cell is really wide.

Last one.

Patient is from Central or South America.

Paracetidioidomycosis.

The yeast form looks like a ship's steering wheel.

What does that mean?

It's one central cell with multiple smaller buds coming off of it all at once.

Looks just like a mariner's wheel.

Now the book has a fascinating little fact about this one.

It says it mostly affects men.

It's one of the weirdest things in mycology.

The fungus actually has a receptor for estrogen.

And when estrogen binds to it, it prevents the mold from turning into the pathogenic yeast form.

Wait, really?

So women are protected by their hormones?

It seems so.

They can inhale the spores, but the estrogen acts like a natural antifungal and stops the infection from taking hold.

That's amazing.

Okay, final group.

The opportunistic mycoses.

And this is what we see in the hospital all the time.

These fungi are everywhere.

On our skin, in the air.

They don't bother healthy people.

But if your immune system is down.

From AIDS, cancer, chemotherapy,

they seize the opportunity.

And the number one offender is Candida.

Candida albicans.

It's part of our normal flora.

But if you take broad -spectrum antibiotics and kill off all the good bacteria, Candida overgrows.

Causing thrush or yeast infections.

In a healthy person, yes.

But in a neutropenic patient, it can get into the blood and be fatal.

The lab test for it is to look for germ tubes.

The yeast sprouts this little hyphal extension when you put it in serum.

Next up, the pigeon fungus.

Cryptococcus neoformans.

You find it in pigeon droppings.

And it's a huge cause of meningitis in AIDS patients.

Its defining feature is a massive polysaccharide capsule.

And you find that with a special stain.

The India ink stain.

The ink is black, but it can't get through the capsule.

So you see this beautiful clear halo around each yeast cell.

Now the book makes a big deal about two molds.

Aspergillus and mucorin.

And it comes down to geometry.

Absolutely critical geometry.

Aspergillus is everywhere.

In someone with old lung cavities from TB, it can form a big fungus ball called an aspergilloma.

Gross.

But when it's invasive, you identify it by its branching.

The hyphae branch at acute 45 -degree angles, V -shaped.

Okay, 45 degrees for aspergillus.

What about mucor?

Eukarmicosis is the stuff of nightmares.

It loves patients with diabetic ketoacidosis.

It grows in the sinuses and can invade directly into the brain.

It is rapidly fatal.

And its angle.

Right angles.

90 -degree branching.

And the hyphae are non -septate.

They don't have cross walls.

So 45 degrees in septate is aspergillus.

90 degrees in non -septate is mucor.

You have to know that distinction.

And the last one is an oddball.

Pneumocystis girovici.

The great pretender.

We used to think it was a protozoan.

It causes PCP, a classic pneumonia, in AIDS patients.

Why is it an oddball?

Because DNA tells us it's a fungus.

But its cell membrane doesn't have ergosterol.

Wait, so if it has no ergosterol, all those drugs we talked about, the azoles, amphotericid?

Completely useless against it.

And that is a huge clinical pearl.

You cannot treat this fungus with antifungal drugs.

So what do you use?

An antibacterial drug.

Sulfamethoxazole or TMP -SMX.

You treat the fungus like a bacterium.

Wow, that's a trap waiting to happen.

It really is.

We have covered so much ground here.

If you had to boil this all down to the absolute must -know takeaways from this chapter, what are they?

Okay, takeaway number one.

Respect the target.

Fungi are eukaryotes.

Their weak points are the ketone in their cell wall and the ergosterol in their membrane.

That's why our drugs work.

Number two.

Location, location, location.

For the systemic pathogens, geography is your best clue.

Desert means coccidioids.

Bat caves mean histoplasma.

And the third and final takeaway.

Context is king.

A fungus that's harmless on the skin can be deadly in the blood.

And you absolutely must know the difference between 45 -degree and 90 -degree branching in a compromised patient.

It could be life or death.

It really is incredible how much work our immune system does every single day just keeping this entire kingdom at bay.

We are inhaling these spores constantly.

The only thing standing between us and a lung full of fungus is a healthy immune system.

A good reminder to take care of it.

Well, thanks for joining us on this deep dive into the fungal jungle.

From the Last Minute Lecture Team, good luck with your studies.

Be healthy, everyone.

ⓘ This audio and summary are simplified educational interpretations and are not a substitute for the original text.

Chapter SummaryWhat this audio overview covers
Fungi occupy a unique position within microbial pathogens, functioning as eukaryotic organisms that survive as saprophytes in environmental reservoirs while simultaneously acting as parasites when they establish infection in human hosts. Their structural distinctiveness from both plants and bacteria stems from cell wall architecture built on chitin rather than peptidoglycan, coupled with ergosterol-based cell membranes that fundamentally differ from the cholesterol framework found in animal cells. This biochemical composition provides the rationale for clinically employed antifungal strategies, where polyenes disrupt membrane integrity, azoles inhibit ergosterol synthesis, and echinocandins target cell wall integrity. The fungal kingdom encompasses morphologically distinct groups that profoundly influence infection patterns and clinical presentation. Unicellular yeasts propagate through budding, generating daughter cells from the parent organism, while filamentous molds develop extensive branching networks of hyphae that collectively form organized mycelia structures. Many medically important species exhibit dimorphism, a physiological adaptation permitting transformation between yeast and mold phenotypes contingent on environmental variables such as temperature elevation or carbon dioxide concentration. Recognition of infection type depends on anatomical depth and disease trajectory. Superficial mycoses, exemplified by dermatophytic ringworm and athlete's foot, remain localized to keratin-rich tissues where specialized fungi enzymatically degrade structural proteins. Subcutaneous infections typically follow traumatic inoculation events introducing fungal material into deeper tissue layers. Systemic mycoses present substantially greater clinical challenge, particularly respiratory pathogens including those responsible for histoplasmosis and coccidioidomycosis, which establish primary lung infection through inhalation and subsequently disseminate hematogenously to distal sites. Immunocompromised populations face heightened vulnerability to opportunistic species, with candidiasis, invasive aspergillosis, and cryptococcal meningitis representing serious nosocomial and community-acquired threats. Laboratory identification employs selective growth media such as Sabouraud dextrose agar and characterization of sporulation patterns to establish accurate diagnosis and guide therapeutic intervention.

Using this chapter to study? Last Minute Lecture is free and student-run. If it helped, consider supporting the project.

Support LML ♥